Advantage Rehab Physical Therapist Medicare: Medicare Enrolled Practice Location: 1819 Sheridan Ave, Cody, WY 82414 Phone: 307-587-9866 Fax: 307-587-9867 |
Raffie Halajian Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1819 Sheridan Ave, Cody, WY 82414 Phone: 307-587-9866 Fax: 307-587-9867 |
Cornerstone Physical Therapy, Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2129 Haugen St, Cody, WY 82414 Phone: 970-310-4524 |
Mrs. Casey Hammond, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 544 Yellowstone Ave, Cody, WY 82414 Phone: 307-587-9789 Fax: 307-587-9787 |
Miss Angela Mae Marchant, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1819 Sheridan Ave., Cody, WY 82414 Phone: 307-587-9866 Fax: 307-587-9867 |
News Archive
If health care costs continue to grow at the same rate as the last 40 years, income tax rates will need to increase substantially by 2050 if they are the only mechanism used to pay for the additional costs, according to a Congressional Budget Office report released on Monday, CQ HealthBeat reports.
Women and men are not receiving effective diagnostic testing and treatments of osteoporosis, a life threatening condition affecting millions of Americans, according to an expert today at the American Association of Clinical Endocrinologists (AACE) 21st Annual Meeting & Clinical Congress in Philadelphia.
Portico Systems, the leader in Integrated Provider Management (IPM) solutions, and SDI, a leader in healthcare informatics, are announcing a new partnership. This partnership will integrate Portico's provider management platform with SDI's extensive provider data and managed care analytics to enable health plans to intelligently target providers for recruitment, enhance provider performance management programs, and increase decision support to members via enhanced provider profiles.
Salix Pharmaceuticals, Ltd. today announced that the Company has acquired rights to Lumacan™ from Photocure, a Norwegian specialty pharmaceutical company. Lumacan is a novel agent designed to assist in the detection of precancerous and cancerous lesions in the colon.
EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel central nervous system (CNS) therapies, today presented pharmacokinetic and pharmacodynamic data along with the previously reported statistically significant clinical results from its Phase 2b clinical trial of EVP-6124, a novel alpha-7 agonist, in patients with Alzheimer's disease.
› Verified 7 days ago